| Title |
A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
|
|---|---|
| Published in |
Cancer Chemotherapy and Pharmacology, November 2013
|
| DOI | 10.1007/s00280-013-2339-y |
| Pubmed ID | |
| Authors |
Ana M. Molina, Thomas E. Hutson, James Larkin, Anne M. Gold, Karen Wood, Dave Carter, Robert Motzer, M. Dror Michaelson |
Mendeley readers
The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 1% |
| Spain | 1 | 1% |
| Switzerland | 1 | 1% |
| Unknown | 87 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 18% |
| Student > Bachelor | 13 | 14% |
| Other | 13 | 14% |
| Student > Master | 12 | 13% |
| Student > Doctoral Student | 11 | 12% |
| Other | 13 | 14% |
| Unknown | 12 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 42 | 47% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 9% |
| Biochemistry, Genetics and Molecular Biology | 6 | 7% |
| Nursing and Health Professions | 6 | 7% |
| Agricultural and Biological Sciences | 6 | 7% |
| Other | 5 | 6% |
| Unknown | 17 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2023.
All research outputs
#1,802,598
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#36
of 2,501 outputs
Outputs of similar age
#17,413
of 217,315 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#1
of 33 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 217,315 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.